Last reviewed · How we verify

NCT02484820: PREMAPESSAIRE

Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor

Completed NA Last updated 24 May 2023
What this trial tests

NA trial testing Silicone pessary in Preterm Birth in 168 participants. Completed in 31 January 2023.

Timeline
1 December 2015
Primary endpoint
8 October 2022
31 January 2023

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Saint Etienne
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment168
Start date1 December 2015
Primary completion8 October 2022
Estimated completion31 January 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Who can join

18 and older, female only, with Preterm Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In France, threatened preterm labour concerns 6.5% of pregnancies and is associated with a premature birth in 25.4% of cases. After 48 hours effective tocolysis, patients do not receive any further treatment while their risk of premature birth has risen from 6.5% to 25%. A pessary is a silicone ring encircling the cervix. It was initially used as medical treatment of genital prolapse but studies were also conducted for pregnant women in 2 high-risk premature birth situations: cervical incompetence and twin pregnancies. The multicenter PECEP trial conducted by Goya and al. in asymptomatic short cervix patients between 18 and 22 weeks of gestation showed a significant reduction of premature birth before 34 and 37 weeks of gestation. Thereby, the investigator assume that use of pessaries in patients presenting a resolutive threatened preterm labor will also be effective. To evaluate this hypothesis, the investigator designed a randomized prospective single-center open clinical trial comparing pessary associated with standard care (1st group) versus standard care only (2nd group) in patients experiencing an episode of resolutive threatened preterm labor.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cervical pessary for preventing preterm birth in singleton pregnancies.
    Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA, Aboelfadle Mohamed A. · · 2022 · cited 10× · PMID 36453699 · DOI 10.1002/14651858.cd014508

Verify or expand the search:

Other recruiting trials for Preterm Birth

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Saint Etienne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02484820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing